BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9685888)

  • 1. Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates.
    Bernkop-Schnürch A; Krajicek ME
    J Control Release; 1998 Jan; 50(1-3):215-23. PubMed ID: 9685888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro evaluation of chitosan-EDTA-protease-inhibitor conjugates which might be useful in oral delivery of peptides and proteins.
    Bernkop-Schnürch A; Scerbe-Saiko A
    Pharm Res; 1998 Feb; 15(2):263-9. PubMed ID: 9523313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel bioadhesive chitosan-EDTA conjugate protects leucine enkephalin from degradation by aminopeptidase N.
    Bernkop-Schnürch A; Paikl C; Valenta C
    Pharm Res; 1997 Jul; 14(7):917-22. PubMed ID: 9244150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro study of different chitosan-complexing agent conjugates.
    Bernkop-Schnürch A; Freudl J
    Pharmazie; 1999 May; 54(5):369-71. PubMed ID: 10368830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal peptide and protein delivery: novel bioadhesive drug-carrier matrix shielding from enzymatic attack.
    Bernkop-Schnürch A; Pasta M
    J Pharm Sci; 1998 Apr; 87(4):430-4. PubMed ID: 9548894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan and its derivatives: potential excipients for peroral peptide delivery systems.
    Bernkop-Schnürch A
    Int J Pharm; 2000 Jan; 194(1):1-13. PubMed ID: 10601680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and in vitro evaluation of a drug delivery system based on chitosan-EDTA BBI conjugate.
    Bernkop-Schnürch A; Krauland A; Valenta C
    J Drug Target; 1998; 6(3):207-14. PubMed ID: 9888307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiolated polymers--thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates.
    Kast CE; Bernkop-Schnürch A
    Biomaterials; 2001 Sep; 22(17):2345-52. PubMed ID: 11511031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiolated polymers--thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates.
    Bernkop-Schnürch A; Hornof M; Zoidl T
    Int J Pharm; 2003 Jul; 260(2):229-37. PubMed ID: 12842342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional adhesive polymers: Preactivated thiolated chitosan-EDTA conjugates.
    Netsomboon K; Suchaoin W; Laffleur F; Prüfert F; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2017 Feb; 111():26-32. PubMed ID: 27865931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemically modified chitosans as enzyme inhibitors.
    Bernkop-Schnürch A; Kast CE
    Adv Drug Deliv Rev; 2001 Nov; 52(2):127-37. PubMed ID: 11718936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral peptide drug delivery: polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitro.
    Marschütz MK; Bernkop-Schnürch A
    Biomaterials; 2000 Jul; 21(14):1499-507. PubMed ID: 10872779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycarbophil-cysteine conjugates as platforms for oral polypeptide delivery systems.
    Bernkop-Schnürch A; Thaler SC
    J Pharm Sci; 2000 Jul; 89(7):901-9. PubMed ID: 10861591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of polymeric excipients protecting calcitonin against degradation by intestinal serine proteases.
    Guggi D; Bernkop-Schnürch A
    Int J Pharm; 2003 Feb; 252(1-2):187-96. PubMed ID: 12550794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
    Krauland AH; Guggi D; Bernkop-Schnürch A
    J Control Release; 2004 Mar; 95(3):547-55. PubMed ID: 15023465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo.
    Luessen HL; de Leeuw BJ; Langemeÿer MW; de Boer AB; Verhoef JC; Junginger HE
    Pharm Res; 1996 Nov; 13(11):1668-72. PubMed ID: 8956332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of chitosan-EDTA conjugate polyplexes as a nanoparticulate gene delivery system.
    Loretz B; Bernkop-Schnürch A
    AAPS J; 2006; 8(4):E756-64. PubMed ID: 17285741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan-EDTA conjugate: a novel polymer for topical gels.
    Valenta C; Christen B; Bernkop-Schnürch A
    J Pharm Pharmacol; 1998 May; 50(5):445-52. PubMed ID: 9643436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole.
    Kast CE; Valenta C; Leopold M; Bernkop-Schnürch A
    J Control Release; 2002 Jun; 81(3):347-54. PubMed ID: 12044573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of a chitosan-aprotinin conjugate for the peroral delivery of therapeutic peptides and proteins susceptible to enzymatic degradation.
    Werle M; Loretz B; Entstrasser D; Föger F
    J Drug Target; 2007 Jun; 15(5):327-33. PubMed ID: 17541841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.